asulacrine has been researched along with Lung Neoplasms in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (76.92) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atwell, GJ; Baguley, BC; Denny, WA; Rewcastle, GW | 1 |
| Atwell, GJ; Baguley, BC; Denny, WA; Finlay, GJ; Rewcastle, GW; Twigden, SJ; Wilson, WR | 1 |
| Baguley, BC; Grove, W; Hardy, JR; Harvey, VJ; Smith, S | 1 |
| Baguley, BC; Finlay, GJ | 2 |
| Baguley, BC; Evans, PC; Jurlina, JL; Kestell, P; Paxton, JW; Robertson, IG; Young, D | 1 |
| Clark, GM; Elslager, EE; Lathan, B; Von Hoff, DD | 1 |
| Baguley, BC; Calveley, SB; Harvey, VJ | 1 |
| Baguley, BC; Finlay, GJ; Wilson, WR | 2 |
| Baguley, BC; Corbett, TH; Griswold, DP; Leopold, WR; Plowman, J | 1 |
| Baguley, BC; Wilson, WR | 1 |
| Baguley, BC; Grimwade, CD; Kernohan, AR | 1 |
13 other study(ies) available for asulacrine and Lung Neoplasms
| Article | Year |
|---|---|
Potential antitumor agents. 48. 3'-Dimethylamino derivatives of amsacrine: redox chemistry and in vivo solid tumor activity.
Topics: Amsacrine; Animals; Antineoplastic Agents; Carcinoma; Cell Line; Chemical Phenomena; Chemistry; Colonic Neoplasms; DNA; Humans; Leukemia, Experimental; Lung Neoplasms; Mice; Oxidation-Reduction; Structure-Activity Relationship | 1987 |
Synthesis, antitumor activity, and DNA binding properties of a new derivative of amsacrine, N-5-dimethyl-9-[(2-methoxy-4-methylsulfonylamino) phenylamino]-4-acridinecarboxamide.
Topics: Aminoacridines; Amsacrine; Animals; Antineoplastic Agents; Cattle; Cell Division; Cell Line; Cell Survival; Cricetinae; DNA; Drug Evaluation, Preclinical; Humans; Indicators and Reagents; Intercalating Agents; Leukemia L1210; Leukemia P388; Lung Neoplasms; Mice; Mice, Inbred Strains; Thymus Gland | 1984 |
Phase II study of the amsacrine analogue CI-921 (NSC 343499) in non-small cell lung cancer.
Topics: Adult; Aged; Amsacrine; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Neutropenia; Seizures | 1991 |
Potentiation by phenylbisbenzimidazoles of cytotoxicity of anticancer drugs directed against topoisomerase II.
Topics: Acridines; Amsacrine; Animals; Antineoplastic Agents; Benzimidazoles; Bisbenzimidazole; Colonic Neoplasms; Doxorubicin; Drug Synergism; Etoposide; Fluorescent Dyes; Leukemia L1210; Lung Neoplasms; Melanoma; Mice; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1990 |
Disposition of amsacrine and its analogue 9-([2-methoxy-4-[(methylsulfonyl)amino]phenyl]amino)-N,5-dimethyl-4- acridinecarboxamide (CI-921) in plasma, liver, and Lewis lung tumors in mice.
Topics: Amsacrine; Animals; Antineoplastic Agents; Carcinoma; Liver; Lung Neoplasms; Male; Metabolic Clearance Rate; Mice; Solubility | 1990 |
Selectivity of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide towards Lewis lung carcinoma and human tumour cell lines in vitro.
Topics: Acridines; Aminoacridines; Amsacrine; Animals; Antineoplastic Agents; Cell Survival; Dose-Response Relationship, Drug; Doxorubicin; Humans; Lung Neoplasms; Mice; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1989 |
Evaluation of an amsacrine analog in a human tumor cloning system.
Topics: Amsacrine; Antineoplastic Agents; Breast Neoplasms; Colonic Neoplasms; Drug Resistance; Humans; Lung Neoplasms; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1989 |
Effects of CI-921, an analogue of amsacrine, on advanced Lewis lung tumours in mice: relevance to clinical trials.
Topics: Amsacrine; Animals; Antineoplastic Agents; Dose-Response Relationship, Drug; Flow Cytometry; Lung; Lung Neoplasms; Mice; Time Factors; Tumor Cells, Cultured | 1988 |
Cytokinetic factors in drug resistance of Lewis lung carcinoma: comparison of cells freshly isolated from tumours with cells from exponential and plateau-phase cultures.
Topics: Amsacrine; Animals; Antineoplastic Agents; Cell Survival; Doxorubicin; Drug Resistance; Interphase; Lung Neoplasms; Mice; Mice, Inbred Strains; Mitosis; Time Factors; Tumor Cells, Cultured | 1987 |
Experimental antitumor activity of the amsacrine analogue CI-921.
Topics: Amsacrine; Animals; Antineoplastic Agents; Cell Line; Colonic Neoplasms; Disease Models, Animal; Drug Evaluation, Preclinical; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains | 1987 |
Comparison of in vivo and in vitro drug sensitivities of Lewis lung carcinoma and P388 leukaemia to analogues of amsacrine.
Topics: Amsacrine; Animals; Antineoplastic Agents; Cell Line; Drug Evaluation, Preclinical; Female; Leukemia P388; Leukemia, Experimental; Lung Neoplasms; Mice; Neoplasm Transplantation; Tumor Stem Cell Assay | 1987 |
Cytokinetic resistance of Lewis lung carcinoma to cyclophosphamide and the amsacrine derivative CI-921.
Topics: Amsacrine; Animals; Antineoplastic Agents; Cell Cycle; Cell Line; Cyclophosphamide; Drug Resistance; Lung Neoplasms; Mice; Neoplasms, Experimental; Tumor Stem Cell Assay | 1986 |
Schedule dependence of activity of the amsacrine analogue CI-921 towards P388 leukaemia and Lewis lung carcinoma.
Topics: Aminoacridines; Amsacrine; Animals; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Injections, Intraperitoneal; Leukemia P388; Leukemia, Experimental; Lung Neoplasms; Male; Mice; Mice, Inbred Strains | 1985 |